Peter Markland

Dr. Peter Markland is a Pharmaceutical scientist with over 20 years of experience in drug delivery research, technology, and biomaterials development. His expertise includes directing internal drug delivery research and product development teams, and evaluating external delivery technologies. Dr Markland has also been involved in program management and marketing for novel, controlled release dosage forms and have experience in formulation development of a wide variety of drugs for various routes of administration.

Frederic Dargelas

Dr. Frederic Dargelas is the Director, Head of Business Development and Alliance Management of DelSiTech. He joined the company in 2019. Dr. Dargelas is a business development and R&D veteran with almost 20 years of experience in the pharma and biotech industry. Previously, he held managing positions at diverse international companies such as GSK and Orion Pharma. Dr. Dargelas holds a PhD in Physical Chemistry of Polymers and an MBA.

Dr. Loutjie Coetzee

Dr. Loutjie Coetzee is the MetOptima Product Manager at Draslovka, and is based in South Africa.

Loutjie has over 16 years of experience in the minerals processing industry, specializing in advanced process control.

He holds a PhD in Electronic Engineering from The University of Pretoria where he completed his doctoral thesis on predictive control of closed run-of-mine ore milling circuits. Loutjie spent several years at Mintek and served as a guest lecturer at The University of Pretoria before joining Draslovka in 2024.

Anthony Bandmann

Education
• Business Management Saarland University, Saarbrücken

Professional experience
• 1997 – 2000
MLP AG – Financial Consultant
• 2000 – 2007
Daimler Financial Services AG – Various functions with time abroad (2001 – 2007) in
the USA at the Companies Daimler Truck Financial and Chrysler Financial
• 2007 – 2009
Mercedes Benz AG in Stuttgart, Director for Private and Corporate Business
• 2009 – 2012
Mercedes Benz AG in Stuttgart, Member of the Board for Private and Corporate
Business
• 2012 – 2017
Managing Director at Volkswagen Bank GmbH in Braunschweig
• 2017 – 2019
Managing Director at Volkswagen Leasing GmbH in Braunschweig
• 2019 – 2021
CEO & President VW Credit Inc. in USA
• from 1st October 2021 – CSO Volkswagen Financial Services in Braunschweig

Daniel Molina

Daniel is an internationally recognised keynote speaker, evangelist and spokesperson, with published articles in the area of cybersecurity, privacy, and reducing your risk on security investments. Daniel has led many teams to success at Kaspersky, McAfee, and IBM.

Jamie Gamerman

Jamie Gamerman, J.D., is a Senior Policy Advisor at the Food and Drug Administration (FDA) in the Center for Drug Evaluation and Research, Office of Medical Policy, where she advises on regulatory policy issues. Jamie has worked at the FDA since 2014 and is also a member of the Food and Drug Law Institute’s Food and Drug Law Journal Editorial Advisory Board.

Mathilda Fienkeng

CAPTAIN Mathilda Fienkeng, PharmD, MS, serves as the Director of the Division of Medical Policy Development, in the Center of Drug Evaluation and Research’s Office of Medical Policy at the Food and Drug Administration. In this role, CAPT Fienkeng provides leadership, oversight, and direction to a diverse staff of medical, pharmacy, public health, legal, project management and administrative professionals in the development of new and ongoing policy initiatives pertaining to human drug development, human drug approval, bioresearch monitoring, and human subject protection. She joined FDA in 2008 and has public health experience in prescription drug advertising and promotional labeling review, surveillance and enforcement, drug shortage, and domestic and international emergency response. Prior, she worked as a registered nurse and a Secondary Education Teacher. CAPT Fienkeng was commissioned in the U.S. Public Health Service in 2008 and holds the rank of Captain (O-6). She earned a Doctor of Pharmacy degree and a Master of Science in Regulatory Science from the University of Maryland School of Pharmacy, an executive certificate in Public Policy from Harvard Kennedy School of Executive Education, an Associate of Science in Nursing from Essex Community College, Baltimore MD, and a Bachelor of Arts in Bilingual Education from Ecole Normale Supérieure, University of Yaoundé I, Cameroon.